Hopp til innhold
NHI.no
Annonse

Prognose ved erythema multiforme

Innhold i artikkelen

Erytema multiforme

I de fleste tilfeller har tilstanden et mildt forløp over en til to uker, sykdommen er over etter to til fire uker og den etterlater ingen varige forandringer.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Erythema multiforme . Referanselisten for dette dokumentet vises nedenfor

  1. Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician 2006; 74: 1883-8. PubMed
  2. Ayangco L, Rogers RS III. Oral manifestations of erythema multiforme. Dermatol Clin 2003; 21: 195-205. PubMed
  3. Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin North Am 2004; 24: 357-71. PubMed
  4. Zimmermann S, Sekula P, Venhoff M, et al. Systemic Immunomodulating Therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis. A systematic review and meta-analysis. JAMA Dermatol. 2017;153(6):514-522 . doi:10.1001/jamadermatol.2016.5668 DOI
  5. Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am 2005; 49: 67-76. PubMed
  6. Kowal-Vern A. Erythema multiforme. BMJ Best Practice, last updated December 2018. bestpractice.bmj.com
  7. Sollesnes Holsen D, Johannessen AC. Sykdommer som affiserer hud og munnslimhinne. Tidsskr Nor Lægeforen 2006; 126: 1214-7. Tidsskrift for Den norske legeforening
  8. Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003; 9: 1. PubMed
  9. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, for the SCAR Study Group. Severe cutaneous adverse reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 1019-24. PubMed
  10. Shin HT, Chang MW. Drug eruptions in children. Curr Probl Pediatr 2001; 31: 207-34. PubMed
  11. Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000; 83: 347-52. PubMed
  12. Lam NS, Yang YH, Wang LC, Lin YT, Chiang BL. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect 2004; 37: 366-70. PubMed
  13. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018;54:177-184. PubMed
  14. Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012 Aug. 51(8):889-902.
  15. Foster CS. Stevens-Johnson syndrome. Medscape, last updated Jan 17, 2019. emedicine.medscape.com
  16. Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology 2003; 207: 349-53. PubMed
Annonse
Annonse